MARK WALBERG, M.D.
Medical Oncology Physician · DALLAS, TX
Individual Active NPI 1306884333
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 421 | 72,795 | $5,707,356 | $1,679,042 | $1,337,313 |
| 2023 | 445 | 98,109 | $7,097,205 | $2,044,197 | $1,627,717 |
| 2022 | 438 | 82,439 | $6,048,252 | $1,876,837 | $1,496,284 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 9,000 | $56 | $45 |
| J1756 | Injection, iron sucrose, 1 mg | 7,000 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 6,300 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,999 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 3,060 | $49 | $39 |
| J9267 | Injection, paclitaxel, 1 mg | 2,894 | $0 | $0 |
| J1930 | Injection, lanreotide, 1 mg | 1,680 | $48 | $38 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 960 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 580 | $1 | $1 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 460 | $0 | $0 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 263 | $5 | $4 |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 187 | $28 | $22 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | J6272 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1962595090
- NPI 1407898505
- NPI 1821257072
- NPI 1225328743
- NPI 1528591047
- NPI 1326368895
- NPI 1154530830
- NPI 1235171281
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.